B2bmart360India's largest online marketplace, B2bmart 360 connects manufacturers, exporters, distributors & suppliers for seamless trade. Reliable, transparent platformhttps://www.b2bmart360.com/s/645a2cfc40fed60b90247247/66066d164cf03f27fbe4f178/b2bmart360-logo-480x480.jpeg
Unit No. 458, Plot No. E-5, Aggarwal Metro Height NSP, Pitampura-110034IN
B2bmart360
Unit No. 458, Plot No. E-5, Aggarwal Metro Height NSP, Pitampura, IN
+918375098857https://www.b2bmart360.com/s/645a2cfc40fed60b90247247/66066d164cf03f27fbe4f178/b2bmart360-logo-480x480.jpeg"[email protected]
66beeb497df8ac02f1ec5de0Bortezomib (M-PRIB-2 Injection )Bortezomib (M-PRIB-2 Injection )
Dose/Strength2 mg
Packaging TypeVial
BrandCadila
Manufactured ByCadila pharmaceutical
Usage/ApplicationHospital
Shelf life36


Bortezomib injection is used to treat multiple myeloma (blood plasma cell cancer) in patients with or without a previous history of treatment, and mantle cell lymphoma. Bortezomib is an antineoplastic agent (cancer medicine). It interferes with the growth of cancer cells and multiple myeloma (a type of cancer of the bone marrow)., which are eventually destroyed by the body

SKU-YCNIR2O6O
INR15000In Stock
11

Bortezomib (M-PRIB-2 Injection )

₹15,000

Related Products